Amanote Research

Amanote Research

    RegisterSign In

Common Theme for Drugs Effective in Overactive Bladder Treatment: Inhibition of Afferent Signaling From the Bladder

International Journal of Urology - United Kingdom
doi 10.1111/j.1442-2042.2012.03196.x
Full Text
Open PDF
Abstract

Available in full text

Categories
Urology
Date

October 17, 2012

Authors
Brandy HoodKarl-Erik Andersson
Publisher

Wiley


Related search

OnabotulinumtoxinA for the Treatment of Overactive Bladder

Research and Reports in Urology
Urology
2014English

Refractory Overactive Bladder: A Common Problem?

International Urogynecology Journal
GynecologyUrologyObstetrics
2015English

Stepwise Treatment for Overactive Bladder Is Prudent

Canadian Urological Association Journal
Urology
2017English

Botulinum Toxin a for the Treatment of Overactive Bladder

Toxins
MutagenesisToxicologyHealth
2016English

Correction To: Imidafenacin for the Treatment of Overactive Bladder

Expert Opinion on Pharmacotherapy
MedicinePharmacology
2013English

AE9C90CB: A Novel, Bladder-Selective Muscarinic Receptor Antagonist for the Treatment of Overactive Bladder

British Journal of Pharmacology
Pharmacology
2010English

Pelvic Electrical Neuromodulation for the Treatment of Overactive Bladder Symptoms

Advances in Urology
GynecologyUrologyObstetrics
2011English

Sacral Neuromodulation for Treatment of Overactive Bladder: A Review

Revista de Medicina
2018English

Management of Overactive Bladder

2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy